COVID-19 Info and Resources
for the NYC Community

New York City medical and graduate students on a mission to connect New Yorkers with COVID-19 community resources, policy updates, health information and, most importantly, each other.

Key Updates


All school districts in the state are cleared to open for in-person classes for the fall semester.

As of August 3, New York has officially conducted 6 million COVID19 diagnostic tests. 

The special enrollment for uninsured New Yorkers is extended until August 15, 2020. New Yorkers can apply for coverage through NY State of Health or directly through insurers, and must apply within 60 days of losing coverage.

For the 2020-2021 school year, NYC schools plan to have students learn in-person on some days each week and online on other days. Students and their families can opt to learn remotely everyday if they wish. If you would like your child to continue fully remote learning in the fall, fill out this form here by August 7.  More details regarding the plan can be found here.
New York City will provide free childcare for 100,000 children in the fall.

Visit to find out which phase of reopening your region is in, industry guidance for each phase, regional dashboards for monitoring how the virus is being contained, and information on loans for small businesses.


As of August 13, the world has reached the grim milestone of 20 million coronavirus cases. According to Johns Hopkins University, the case numbers have doubled from 10 million to 20 million in the span of 6 weeks - a shocking statistic given that it took just over 6 months for 10 million confirmed cases to emerge.

Vaccine Status Updates:

As of July 28, Moderna and Pfizer commenced phase 3 clinical trials in the US. 

The Oxford Vaccine-A phase I/II trial of a candidate for a COVID-19 vaccine, ChAdOx1 nCoV-19, showed that it was a safe, easily tolerated, potential vaccine that produced T-cells and antibodies in its recipients. Check out our Instagram post to learn more about the study design and findings. 

The CanSino Vaccine- A phase II clinical trial for a recombinant adenovirus type-5-vectored COVID-19 vaccine from CanSino tested two dosages(5*10^10 viral particles/mL or 1*10^11 viral particles/mL). Both experimental groups produced robust antibody response, significantly different from the placebo group. A significant number of humans carry immunity to the Ad5 vector and while this may decrease side effects, it also was shown to decrease antibody responses elicited by the vaccine and thus people with prior immunity/older individuals may have less protection. To learn more, check out our Instagram post

Latest guidelines and updates from the CDC here.

Updated national cases here.

We post new key updates every day, so visit our website daily for the latest info!

For more updates, visit our Policy Updates page.

News & Research

(as of 8/11)


Confirmed Cases



While this number will continue to rise, the number of cases is a reflection of our ability to TEST.  Many people with COVID-19 have not been tested, meaning the true number is much higher.


CDC COVID-19 Latest News
WHO Rolling Updates
Medical News Today: COVID-19 Live Updates
Stat News: Coronavirus Coverage


LitCovid Maintained open-resource literature hub. The articles are categorized by topic—overview, disease mechanism, transmission dynamics, treatment, case report and epidemic forecasting—as well as by geographic location for visualization on a world map.

COVID PapersAn updated collection of COVID-19 papers collected by University of California San Francisco.

Yale Literature DatabaseDatabase of COVID-19 literature maintained by Yale Harvey Cushing/John Hay Whitney Medical Library, organized by region, by source, and by topic.

NYU COVID Literature ReviewsOne-line and one-page summaries of the most recent and relevant COVID-19 research, produced by students, physicians, and scientists at NYU.

Follow @litcovid_nyu on Twitter for research updates.

NYCovidConnect Instagram

Questions about COVID-19? Ask NYC medical and graduate students using our Instagram!

We also post daily updates on important initiatives around NYC and PSAs on key health-related topics.